2.51
price down icon1.18%   -0.03
after-market 시간 외 거래: 2.50 -0.010 -0.40%
loading
전일 마감가:
$2.54
열려 있는:
$2.45
하루 거래량:
99,306
Relative Volume:
0.03
시가총액:
$87.96M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.1975
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
-4.92%
1개월 성능:
-18.77%
6개월 성능:
+84.89%
1년 성능:
+2.45%
1일 변동 폭
Value
$2.41
$2.54
1주일 범위
Value
$2.1805
$2.72
52주 변동 폭
Value
$0.952
$9.08

Tharimmune Inc Stock (THAR) Company Profile

Name
명칭
Tharimmune Inc
Name
전화
302-743-2995
Name
주소
1200 ROUTE 22 EAST, BRIDGEWATER
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-08-05
Name
최신 SEC 제출 서류
Name
THAR's Discussions on Twitter

THAR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
THAR
Tharimmune Inc
2.51 89.01M 0 -9.32M -7.30M -12.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.82 107.58B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.32 80.03B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
429.80 57.37B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.93 55.83B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
209.02 44.13B 447.02M -1.18B -906.14M -6.1812

Tharimmune Inc 주식(THAR)의 최신 뉴스

pulisher
Nov 22, 2025

Crypto Company Creates Bizarre Drug - Futurism

Nov 22, 2025
pulisher
Nov 21, 2025

Tharimmune Stock Plummets -46% With 9-Day Losing Streak - Trefis

Nov 21, 2025
pulisher
Nov 20, 2025

Using Bollinger Bands to evaluate Tharimmune Inc.Gap Up & Expert Curated Trade Setups - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Tharimmune Inc. stock benefit from sector rotationPortfolio Performance Report & Free Accurate Trade Setup Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts upgrade Tharimmune Inc. stockJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How resilient is Tharimmune Inc. stock in market downturnsWatch List & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Tharimmune Inc. stock a buy for dividend growthTrade Exit Summary & Stepwise Swing Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What insider trading reveals about Tharimmune Inc. stock2025 Momentum Check & Safe Capital Growth Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Tharimmune Inc. stock attractive for retirement portfoliosWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Tharimmune Inc. stock deliver long term returnsInsider Selling & Verified Momentum Stock Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What the charts say about Tharimmune Inc. todayMarket Risk Report & Pattern Based Trade Signal System - newser.com

Nov 19, 2025
pulisher
Nov 16, 2025

Will earnings trigger a reversal in Tharimmune Inc.July 2025 Sentiment & Expert Verified Movement Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Using data models to predict Tharimmune Inc. stock movementWeekly Investment Summary & Accurate Buy Signal Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Will Tharimmune Inc. stock sustain high P E ratiosWall Street Watch & High Accuracy Swing Entry Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Is Tharimmune Inc. still worth holding after the dip2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Tharimmune Shares Jump After FDA Signals Support for TH104 Modeling Plan - MSN

Nov 13, 2025
pulisher
Nov 13, 2025

Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset - MarketScreener

Nov 13, 2025
pulisher
Nov 13, 2025

Tharimmune rises after US FDA backs opioid overdose prevention drug plan - TradingView

Nov 13, 2025
pulisher
Nov 13, 2025

Tharimmune stock rises after FDA provides positive feedback on TH104 By Investing.com - Investing.com Nigeria

Nov 13, 2025
pulisher
Nov 13, 2025

Tharimmune stock rises after FDA provides positive feedback on TH104 - Investing.com

Nov 13, 2025
pulisher
Nov 13, 2025

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids - Stock Titan

Nov 13, 2025
pulisher
Nov 10, 2025

Tharimmune appoints Sireesh Appajosyula as interim CFO through year-end - Investing.com

Nov 10, 2025
pulisher
Nov 10, 2025

Tharimmune appoints Sireesh Appajosyula as interim CFO through year-end By Investing.com - Investing.com UK

Nov 10, 2025
pulisher
Nov 10, 2025

Tharimmune appoints Sireesh Appajosyula as interim CFO on Nov 7SEC filing - MarketScreener

Nov 10, 2025
pulisher
Nov 09, 2025

Tharimmune Closes $545M Private Placement for Blockchain Strategy - The Globe and Mail

Nov 09, 2025
pulisher
Nov 07, 2025

Tharimmune makes a pivot into digital assets, raises approximately $540 million via a private placement - MSN

Nov 07, 2025
pulisher
Nov 07, 2025

Tharimmune entered ATM sales agreement worth up to $64.9 millionSEC filing - MarketScreener

Nov 07, 2025
pulisher
Nov 07, 2025

Tharimmune closes $545 million private placement for Canton Coin strategy By Investing.com - Investing.com Australia

Nov 07, 2025
pulisher
Nov 06, 2025

Tharimmune: $545 Million Private Placement Closed To Advance Canton Coin Treasury Strategy - Pulse 2.0

Nov 06, 2025

Tharimmune Inc (THAR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$39.54
price down icon 0.53%
$31.40
price up icon 1.88%
$105.55
price down icon 0.65%
$99.71
price up icon 3.28%
biotechnology ONC
$335.17
price up icon 0.74%
$209.02
price up icon 1.01%
자본화:     |  볼륨(24시간):